Differential impact of adherence to pegylated interferon and ribavirin in the treatment of genotype 1 high viral titer chronic hepatitis C.

Numata, Makoto; Kagawa, Tatehiro; Kojima, Sei-Ichiro; Hirose, Shunji; Nagata, Naruhiko; Shiraishi, Koichi; Watanabe, Norihito; Shiozawa, Hirokazu; Nishizaki, Yasuhiro; Motegi, Shigeyuki; Takashimizu, Shinji; Kamochi, Jun-Ichiro; Wasada, Mitsuru; Ohno, Takashi; Tei, Yoshihiro; Nakano, Atsushi; Yamada, Takuji; Atsukawa, Kazuhiro; Watanabe, Tetsu; Mine, Tetsuya

Numata, Makoto; Kagawa, Tatehiro; Kojima, Sei-Ichiro; Hirose, Shunji; Nagata, Naruhiko; Shiraishi, Koichi; Watanabe, Norihito; Shiozawa, Hirokazu; Nishizaki, Yasuhiro; Motegi, Shigeyuki; Takashimizu, Shinji; Kamochi, Jun-Ichiro; Wasada, Mitsuru; Ohno, Takashi; Tei, Yoshihiro; Nakano, Atsushi; Yamada, Takuji; Atsukawa, Kazuhiro; Watanabe, Tetsu; Mine, Tetsuya.

Afiliación

Numata M; Department of Gastroenterology, Tokai University School of Medicine, Isehara 259-1193, Japan.

Hepat Res Treat ; 2010: 702748, 2010.

Article en En | MEDLINE | ID: mdl-21188199

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Hepat Res Treat Año: 2010 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google